share_log

Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $95

Benzinga ·  Dec 11 23:23  · Ratings

Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $88 to $95.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment